Tag Archives: ‘Innovative Medicines Initiative’

Corporate Europe Observatory report reveals the dramatic extent of the pharmaceutical industry’s lobbying efforts towards EU decision-makers

BRUSSELS, 4-9-2015 — /EuropaWire/ — A new report released today reveals the dramatic extent of the pharmaceutical industry’s lobbying efforts towards EU decision-makers, with the industry spending an estimated 15 times more than civil society actors working on public health … Read the full press release